Related Articles Premium Coatue’s Unicorn Spree Marks Its Busiest VC Quarter in Nearly Four Years Stephen Taub Premium A Quick Windfall for Hedge Funds, Another Blow for a Biotech Company’s Early Backers Stephen Taub Optimizing the Efficient Frontier: Opportunistic Credit Amid a Capital Structure Reset Sponsored by Davidson Kempner